Cell Biochemistry and Function · 2010 · 10 citations · 48 references
MedicineOncologyPharmacologyChemotherapyMedical OncologyMolecular OncologyCancer BiomarkersLung CancerMalignant NeoplasmsChemotherapy Response AssessmentFas LigandFas Ligand-mediated ApoptosisFas-fas Ligand Mediated Killing
The Fas/Fas Ligand (FasL) system and survivin have counteracting roles in cell survival. Therefore, we explored the role of circulating soluble Fas (sFas) and the tissue levels of Fas and survivin with regard to response to chemotherapy in lung cancer patients. Serum samples from 52 lung cancer patients and 54 control subjects (19 benign lung disease and 35 healthy control subjects) were collected prior to and 24 and 48 h after chemotherapy. sFas was statistically significantly higher in the cancer group than that in the control groups (p < 0.001). Baseline (before chemotherapy) sFas values showed a statistically significant inverse correlation with overall survival (r = -0.599, p < 0.001). There was a significant increase in serum sFas levels 24 h after treatment (p < 0.05). Contrarily, tissue levels of Fas and survivin were not changed following the chemotherapy (p > 0,05). In conclusion, increased sFas may be an indicator of poor outcome in lung cancer patients. However, cisplatin-based chemotherapy may not be effective via neither the Fas/FasL system nor survivin pathway. Indeed, larger sample size is required for further evaluation.
48
Ahmedin Jemal, Freddie Bray, Jacques Ferlay et al. · CA A Cancer Journal for Clinicians · 2011 · 55K citations · Full text
Donald Maxwell Parkin, Paola Pisani, Jacques Ferlay · CA A Cancer Journal for Clinicians · 1999 · 3.4K citations · Full text
Control of apoptosis and mitotic spindle checkpoint by survivin
Fengzhi Li, Grazia Ambrosini, Emily Chu et al. · Nature · 1998 · 1.9K citations
Protection from Fas-Mediated Apoptosis by a Soluble Form of the Fas Molecule
Jianhua Cheng, Tong Zhou, Changdan Liu et al. · Science · 1994 · 1.1K citations